Trial Profile
A phase III trial of Arasertaconazole for the treatment of vulvovaginal candidiasis (VVC)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Jan 2016
Price :
$35
*
At a glance
- Drugs Arasertaconazole (Primary)
- Indications Vulvovaginal candidiasis
- Focus Therapeutic Use
- 15 Jan 2016 New trial record